期刊文献+

达沙替尼的合成工艺优化研究 被引量:2

Optimization of Synthesis Technology of Dastinib
下载PDF
导出
摘要 以2-氨基噻唑-5-甲酸乙酯为原料,经过氨基保护、水解、经酰氯成酰胺、脱保护和两步亲核取代反应,合成了达沙替尼,反应总收率达53.4%。目标化合物经质谱、核磁共振氢谱确证结构。该合成工艺优化了反应条件,降低了生产成本,具有工业化生产前景。 Dasatinb was synthesized from ethyl 2-aminothiazole-5-carboxylate through a series reactions including N-Boc protection, hydrolysis, chlorination, amidation, deprotection and two steps of nucleophilic substitution in an overall yield of 53.4%. MS and1 H NMR were used for structure identification. This technology provided a prospect for industrial production by optimizing the reaction conditions and reducing the production cost.
作者 谭桂林 黄本东 TAN Gui-lin HUANG Ben-dong(School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China)
出处 《精细化工中间体》 CAS 2016年第5期18-21,24,共5页 Fine Chemical Intermediates
关键词 络氨酸激酶抑制剂 达沙替尼 2-氨基噻唑-5-甲酸乙酯 tyrosine kinase inhibitor dasatinb ethyl 2-aminothiazole-5-carboxylate
  • 相关文献

参考文献4

二级参考文献21

  • 1SHAH N P. Dasatinib [ J ]. Drugs Today, 2007,43 (1):5.
  • 2LOMBARDO L J, LEE F Y, CHEN P, et al. Discovery of N-( 2-chloro-6-methyl-pheny 1 ) -2-(6-(4-( 2- hydroxyethyl )-piperazin-1-yl )-2-methylpyrimidin- 4-ylamino) thiazole-5-carboxamide ( BMS-354825 ), a dual src/abl kinase inhibitor with potent antitumor activity in preclinical assays[ J]. J Med Chem,2004, 47 (27) : 6658 - 6661.
  • 3CHEN B, DROGHINI R, LAJEUNESSE J, et al. Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors: WO, 2005/ 077945A2 [ P]. 2005 - 08 - 25.
  • 4FERNANDEZ F, GARCIA-MERA X, MORALES M, et al. A short, efficient synthesis of substituted uracil : an indane carbocyclic nucleoside [ J ]. Synthesis,2001 ( 2 ) :239 - 242.
  • 5Mclntyre JA, Castaner J, Bayes M. Dasatinib: Treatment of leukemia treatment of solid tumors Bcr-Abl and Src kinase inhibitor [J]. Drug Future, 2006, 31 (4): 291-303.
  • 6Das J, Moquin RV, Lin J, et al. Discovery of 2-aminoheteroaryl-benzothiazole-6-anilides as potent p56^kk inhibitors [J]. Bioorg Med Chem Lett, 2003, 13 (15) : 2587-2590.
  • 7Wityak J, Das J, Moquin RV, et al. Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56^Lck [J]. Bioorg Med Chem Lett, 2003, 13 (22) : 4007-4010.
  • 8Lombardo LJ, Lee FY, Chen P, et al. Discovery of N-(2- chloro-6-methylphenyl) -2- (6- (4- (2-hydroxyethyl) - piperazin-1-yl) -2- methylpyrimidin-4-ylamino) thiazole-5- carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays [J]. J Med Chem, 2004, 47 (27): 6658-6661.
  • 9Das J, Chen P, Norris D, et al. 2-Aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro- 6- methylphenyl) -2- [ [ 6- [ 4- (2-hydroxyethyl) - 1 -piperazinyl) ]-2-methyl-4- pyrimidinyl] amino) ]- 1,3-thiazole-5- carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor [J]. J Med Chem, 2006, 49 (23) : 6819-6832.
  • 10Chen BC, Droghini R, Lajeunesse J, et al. Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors: WO, 2005077945 [P]. 2005-08-25. (CA 2005, 143: 248376).

共引文献19

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部